Vistagen Therapeutics, Inc. (VTGN)
0.3079
+0.01
(+3.32%)
USD |
NASDAQ |
Sep 30, 16:00
0.2952
-0.01
(-4.12%)
After-Hours: 20:00
Vistagen Therapeutics Price : 0.3079 for Sept. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 29, 2026 | 0.288 | 0.3049 | 0.2829 | 0.298 | 2.026M |
| Sep 28, 2026 | 0.2702 | 0.319 | 0.268 | 0.297 | 6.030M |
| Sep 25, 2026 | 0.2845 | 0.2973 | 0.2640 | 0.273 | 5.572M |
| Sep 24, 2026 | 0.349 | 0.3599 | 0.2701 | 0.295 | 20.47M |
| Sep 23, 2026 | 0.3861 | 0.5476 | 0.3351 | 0.3684 | 574.96M |
| Sep 22, 2026 | 0.246 | 0.267 | 0.2407 | 0.2514 | 6.000M |
| Sep 21, 2026 | 0.236 | 0.2444 | 0.2325 | 0.233 | 332118.0 |
| Sep 18, 2026 | 0.234 | 0.2532 | 0.234 | 0.24 | 718613.0 |
| Sep 17, 2026 | 0.2352 | 0.2397 | 0.2323 | 0.2336 | 369919.0 |
| Sep 16, 2026 | 0.236 | 0.2398 | 0.226 | 0.2306 | 553567.0 |
| Sep 15, 2026 | 0.246 | 0.2468 | 0.2361 | 0.2361 | 194442.0 |
| Sep 14, 2026 | 0.249 | 0.2497 | 0.2418 | 0.2432 | 239363.0 |
| Sep 11, 2026 | 0.2399 | 0.245 | 0.2325 | 0.237 | 309993.0 |
| Sep 10, 2026 | 0.238 | 0.2442 | 0.2347 | 0.239 | 341100.0 |
| Sep 09, 2026 | 0.2416 | 0.2464 | 0.23 | 0.2355 | 801742.0 |
| Sep 08, 2026 | 0.25 | 0.25 | 0.24 | 0.2434 | 321446.0 |
| Sep 04, 2026 | 0.2462 | 0.2584 | 0.2425 | 0.2428 | 347258.0 |
| Sep 03, 2026 | 0.2513 | 0.2550 | 0.2412 | 0.2462 | 256580.0 |
| Sep 02, 2026 | 0.24 | 0.2539 | 0.24 | 0.246 | 197890.0 |
| Sep 01, 2026 | 0.2473 | 0.2514 | 0.24 | 0.2433 | 596322.0 |
| Aug 31, 2026 | 0.258 | 0.2600 | 0.2434 | 0.255 | 467376.0 |
| Aug 28, 2026 | 0.2569 | 0.2589 | 0.246 | 0.2529 | 449671.0 |
| Aug 27, 2026 | 0.2599 | 0.269 | 0.2529 | 0.257 | 341224.0 |
| Aug 26, 2026 | 0.2515 | 0.269 | 0.2421 | 0.26 | 569365.0 |
| Aug 25, 2026 | 0.245 | 0.252 | 0.2401 | 0.2484 | 712915.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Onconetix, Inc. | 0.79 |
| ACADIA Pharmaceuticals, Inc. | 20.14 |
| Alnylam Pharmaceuticals, Inc. | 246.82 |
| Anika Therapeutics, Inc. | 19.67 |
| Savara, Inc. | 5.15 |
Price Related Metrics
| PS Ratio | 4.940 |
| Price to Book Value | 0.5581 |
| Earnings Yield | -553.7% |
| Market Cap | 13.67M |